Thrombospondin-1 (TSP1) was the first endogenous angiogenesis inhibitor to be identified [4] and its loss is among the critical events in progression of multiple cancers including carcinomas of the breast and colon as well as skin cancers [5, 6]. This evidence concerns the gene THBS1 and skin neoplasm.